GeneBio Systems
Recombinant ILF3 Monoclonal Antibody
Recombinant ILF3 Monoclonal Antibody
SKU:AN301758L
Couldn't load pickup availability
Size::50μL
Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping:Ice bag
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Monoclonal Antibodies;Recombinant Antibodies
Abbreviation:ILF3
Target Synonym:ILF;MMP;Mpp;DRBP;NF-AT;MPHOSPH;TCP;ILF3;CBTF;DRBF;DRBP76;MMP4;MPHOSPH4;MPP4;NF-AT-90;NF110;NF110b;NF90;NF90a;NF90b;NFAR;NFAR-1;NFAR2;TCP110;TCP80;Double stranded RNA binding protein 76;Double-stranded RNA-binding protein 76;Interleukin enhancer binding factor 3;Interleukin enhancer-binding factor 3;M phase phosphoprotein 4;M-phase phosphoprotein 4;NF AT 90;Nuclear factor associated with dsRNA;Nuclear factor of activated T cells 90 kDa;Nuclear factor of activated T-cells 90 kDa;Translational control protein 80
Research Areas:Signal Transduction;Epigenetics and Nuclear Signaling
Conjugation:Unconjugated
Host:Rabbit
Species reactivity:Human;Rat;Mouse
Application:WB;IHC;IF;FCM
Isotype:IgG,κ
Clonality:Monoclonal;Recombinant
Clone NO.:A466
UNIProt ID:Q12906
Accession:
Background:Interleukin enhancer-binding factor 3 (ILF3) is a double-stranded RNA (dsRNA) binding protein that complexes with other proteins, dsRNAs, small noncoding RNAs, and mRNAs to regulate gene expression and stabilize mRNAs. This protein (NF90, ILF3) forms a heterodimer with a 45 kDa transcription factor (NF45, ILF2) required for T-cell expression of interleukin 2. This complex has been shown to affect the redistribution of nuclear mRNA to the cytoplasm. Knockdown of NF45 or NF90 protein retards cell growth, possibly by inhibition of mRNA stabilization. In contrast, an isoform (NF110) of this gene that is predominantly restricted to the nucleus has only minor effects on cell growth when its levels are reduced. Alternative splicing results in multiple transcript variants encoding distinct isoforms. ILF3 exists main two isoforms NFAR-1 (90 kDa) and -2 (110 kDa). Upon viral infection, ILF3 accumulates in the cytoplasm and participates in the innate antiviral response.
Concentration:1 mg/mL
Immunogen:Recombinant human ILF3 fragment
Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification method:Protein A purified
Dilution:WB 1:2000-1:10000;IHC 1:100-1:500;IF 1:50;FCM 1:50-1:100
Calculated MW:95 kDa
ObservedMW:90,110 kDa
